Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate.
about
S-nitrosothiols modulate G protein-coupled receptor signaling in a reversible and highly receptor-specific manner.Sphingosine-1-Phosphate and Its Receptors: A Mutual Link between Blood Coagulation and InflammationEnhancement of neoangiogenesis and follicle survival by sphingosine-1-phosphate in human ovarian tissue xenotransplantsPharmacologic Interventions in Preventing Ovarian Hyperstimulation Syndrome: A Systematic Review and Network Meta-AnalysisLipid phosphate phosphatases regulate lysophosphatidic acid production and signaling in platelets: studies using chemical inhibitors of lipid phosphate phosphatase activityC(6)-Ceramide-Coated Catheters Promote Re-Endothelialization of Stretch-Injured ArteriesRho family Guanine nucleotide exchange factor Brx couples extracellular signals to the glucocorticoid signaling systemReceptor-mediated vascular smooth muscle migration induced by LPA involves p38 mitogen-activated protein kinase pathway activationSphingosine-1-phosphate receptor subtypes differentially regulate smooth muscle cell phenotype.Biological roles of lysophospholipid receptors revealed by genetic null mice: an update.LPA receptor signaling: pharmacology, physiology, and pathophysiology.Autotaxin expression and its connection with the TNF-alpha-NF-kappaB axis in human hepatocellular carcinoma.Atherosclerotic lesion progression changes lysophosphatidic acid homeostasis to favor its accumulation.Lysophosphatidic acid plasma concentrations in healthy subjects: circadian rhythm and associations with demographic, anthropometric and biochemical parameters.Lysophosphatidic acid in atherosclerotic diseasesLipid phosphate phosphatase inhibitors locally amplify lysophosphatidic acid LPA1 receptor signalling in rat brain cryosections without affecting global LPA degradationLysophospholipid mediators in the vasculatureProduction of lysophosphatidic acid in blister fluid: involvement of a lysophospholipase D activityMetabolic pathways and physiological and pathological significances of lysolipid phosphate mediators.Novel advances in shotgun lipidomics for biology and medicine.Lysophosphatidic acid causes endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells.Comprehensive and quantitative analysis of lysophospholipid molecular species present in obese mouse liver by shotgun lipidomics.Platelet interaction with bioactive lipids formed by mild oxidation of low-density lipoprotein.Lipoprotein-associated proteins involved in platelet signaling.Signaling pathway of lysophosphatidic Acid-induced contraction in feline esophageal smooth muscle cells.Therapeutic potential of autotaxin/lysophospholipase d inhibitors.Static platelet adhesion, flow cytometry and serum TXB2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronary artery disease: a randomised cross-over studyLysophosphatidic acid-induced platelet shape change revealed through LPA(1-5) receptor-selective probes and albumin.Beta-arrestins regulate atherosclerosis and neointimal hyperplasia by controlling smooth muscle cell proliferation and migrationIn search of the most efficient fertility preservation strategy for prepubertal boys.Ceramide-1-phosphate in phagocytosis and calcium homeostasisIntensive care treatment of ovarian hyperstimulation syndrome (OHSS).Arterial thrombosis--insidious, unpredictable and deadly.Alterations of specific lipid groups in serum of obese humans: a review.Activatory properties of lysophosphatidic acid on human THP-1 cells.Lysophosphatidic acid as a mediator for proinflammatory agonists in a human corneal epithelial cell line.Phosphorylation and desensitization of the lysophosphatidic acid receptor LPA1.Sphingosine-1-phosphate regulates the expression of adherens junction protein E-cadherin and enhances intestinal epithelial cell barrier function.The role of lysophosphatidic acid receptors in phenotypic modulation of vascular smooth muscle cells.Spider and bacterial sphingomyelinases D target cellular lysophosphatidic acid receptors by hydrolyzing lysophosphatidylcholine.
P2860
Q24798999-9E4E94D0-B659-4D4E-AF03-3517F096FA6CQ26775993-7CF1CCB2-38BD-401F-948C-4282A32FF89CQ27343108-28F756D4-FEF3-48C2-BE83-FEC2CE902064Q28073087-CB06317B-FCE5-4C04-8132-5835A5A6BAE1Q28156404-AD5B3A7E-FDB7-46CF-87EE-91DA164FC614Q28392226-78FD7220-6E5D-4A27-805A-62F5975414CCQ28513869-C373E710-7665-4951-971A-52EFB9482D62Q28582283-46692414-FABB-4AEA-AC60-F86D2D9865F8Q30440617-8F029515-CBEF-486B-A0C4-B7E0E748A2D2Q30487082-0171BA04-30B2-4CE6-9BD3-5167D59E6570Q33825153-2C02B599-59FA-4402-9168-1356894A8CDEQ33842405-6118D95F-C9E2-4D6C-8736-58217CE742AFQ33882610-748CCA29-3CE0-4736-A26A-36AD922510ECQ33922964-E40CA45E-6116-426C-8BB1-5D33CC3A6C25Q34273486-C073FA71-278C-4675-8779-F767A6569EA2Q34300049-E2E0A819-64A9-4BDB-87BA-5A03EB358D2EQ35533485-CBB3677E-3451-4598-AD15-0D4A357E11EAQ35828519-982E9965-314A-4F19-BE57-453510386240Q35839006-9155579F-BABD-444F-A198-4D628F3DFF09Q35878177-A6FFB7AE-B3BC-49F4-ADC4-B5B30E8BFFBAQ35907288-3B254E35-B189-4D58-BB56-7E0BD6A717E5Q36315161-367678DC-25BD-4657-9BDB-D153504F794AQ36551308-7A1B7B10-D184-4362-AEA8-CC59B727D407Q36551313-7E204752-2B44-4D42-9C82-312AE36C33F7Q36789216-A50DE141-A220-4A36-A7F4-0B17096B7BB6Q37049044-31245230-C532-4E2B-B121-93E04DA33744Q37234897-3BEC9BD7-B99A-4D9F-8EA8-E62E79306499Q37375487-31ADFDD9-3043-484C-96C4-AFD500B1D64AQ37383096-90A4225E-7417-4A13-A801-B5D7CA62576CQ37703841-05922E31-EF97-4874-AD8F-199DF7EE7FA9Q37797411-626E14EE-019E-4284-A63E-C927E1459BB1Q37852771-49DE7A43-D466-4C03-BE27-5B13BB233EF5Q37953778-AF749ED1-D77F-4415-84B8-80D20FE72D24Q39023727-5495A94A-E7C8-4A1F-A7DB-B44AD0ECAB72Q40114967-8020CD71-5E72-4072-B470-8448FE180CF2Q40270351-D8ACC657-C68A-4BE9-BEC4-8DED30094CC5Q40515487-058CCBDD-0EB0-47C9-AE39-722D70FF631CQ41854266-EBC20086-35C9-46C8-8123-44F90BF0ED1EQ43276027-59DB8853-CB3A-4FD4-A1E6-CE102629C742Q44734554-296CEE9F-9BB4-4D32-A64F-B5F4074B4484
P2860
Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate.
@ast
Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate.
@en
Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate.
@nl
type
label
Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate.
@ast
Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate.
@en
Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate.
@nl
prefLabel
Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate.
@ast
Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate.
@en
Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate.
@nl
P1476
Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate.
@en
P2093
Wolfgang Siess
P304
P356
10.1016/S1388-1981(02)00173-7
P407
P577
2002-05-01T00:00:00Z